Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
5(36%)
Results Posted
60%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
2
14%
Ph phase_3
1
7%
Ph not_applicable
11
79%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
2(14.3%)
Phase 3Large-scale testing
1(7.1%)
N/ANon-phased studies
11(78.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

5

trials recruiting

Total Trials

14

all time

Status Distribution
Active(7)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting4
Not yet recruiting2
unknown1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
5
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (14.3%)
Phase 31 (7.1%)
N/A11 (78.6%)

Trials by Status

unknown17%
recruiting429%
completed536%
active_not_recruiting17%
not_yet_recruiting214%
terminated17%

Recent Activity

5 active trials
Showing 5 of 14
completednot_applicable

tDCS for Treatment Resistant Obsessive Compulsive Disorder

NCT03304600
recruitingnot_applicable

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NCT06796504
not_yet_recruitingnot_applicable

CnF-DBS for Levodopa-Resistant FOG

NCT07781696
not_yet_recruitingnot_applicable

Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise

NCT07686302
completednot_applicable

Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder

NCT05269953
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT03304600Not Applicable

tDCS for Treatment Resistant Obsessive Compulsive Disorder

Completed
NCT06796504Not Applicable

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Recruiting
NCT07781696Not Applicable

CnF-DBS for Levodopa-Resistant FOG

Not Yet Recruiting
NCT07686302Not Applicable

Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise

Not Yet Recruiting
NCT05269953Not Applicable

Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder

Completed
NCT04539964Phase 3

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Active Not Recruiting
NCT06773286Not Applicable

Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury

Recruiting
NCT03372460Not Applicable

tDCS Plus Virtual Reality for PTSD

Completed
NCT05003310Not Applicable

ConsideRAte Study - Splenic Stimulation for RA

Recruiting
NCT04955899Not Applicable

Safety of Splenic Stimulation for RA

Recruiting
NCT03230695Not Applicable

Robotic Therapy and Brain Stimulation in the Early Phase After Stroke

Unknown
NCT03767192Not Applicable

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A)

Terminated
NCT02152878Phase 2

Transcranial Direct Current Stimulation for the Treatment of Bipolar Depression

Completed
NCT00977652Phase 2

Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Completed

All 14 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
14